I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Automated Immunoassay Analyzers Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Automated
Immunoassay Analyzers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 2: World Historic Review for Automated Immunoassay
Analyzers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 3: World 15-Year Perspective for Automated Immunoassay
Analyzers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Immunofluorescence
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 5: World Historic Review for Immunofluorescence by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 6: World 15-Year Perspective for Immunofluorescence by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Chemiluminescence
Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 8: World Historic Review for Chemiluminescence
Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 9: World 15-Year Perspective for Chemiluminescence
Immunoassay (CLIA) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Enzyme Linked
Fluorescent Immunoassay (ELFA) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 11: World Historic Review for Enzyme Linked Fluorescent
Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 12: World 15-Year Perspective for Enzyme Linked
Fluorescent Immunoassay (ELFA) by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World for Years 2012,
2020 & 2027

Table 13: World Current & Future Analysis for Enzyme Linked
Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 14: World Historic Review for Enzyme Linked Immunosorbent
Assay (ELISA) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 15: World 15-Year Perspective for Enzyme Linked
Immunosorbent Assay (ELISA) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Radioimmunoassay
(RIA) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 17: World Historic Review for Radioimmunoassay (RIA) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 18: World 15-Year Perspective for Radioimmunoassay (RIA)
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027

Table 20: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 21: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019

Table 24: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 25: World Current & Future Analysis for Diagnostic
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027

Table 26: World Historic Review for Diagnostic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 27: World 15-Year Perspective for Diagnostic Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Blood Bank by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 29: World Historic Review for Blood Bank by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019

Table 30: World 15-Year Perspective for Blood Bank by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 32: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 33: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Automated Immunoassay Analyzers Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 34: USA Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 35: USA Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 36: USA 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 38: USA Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 39: USA 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 40: Canada Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 41: Canada Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 42: Canada 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 44: Canada Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 45: Canada 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 47: Japan Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 48: Japan 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 50: Japan Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 51: Japan 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 52: China Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 53: China Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 54: China 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 55: China Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 56: China Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 57: China 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Automated Immunoassay Analyzers Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 58: Europe Current & Future Analysis for Automated
Immunoassay Analyzers by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027

Table 59: Europe Historic Review for Automated Immunoassay
Analyzers by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 60: Europe 15-Year Perspective for Automated Immunoassay
Analyzers by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 61: Europe Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 62: Europe Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 63: Europe 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 64: Europe Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 65: Europe Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 66: Europe 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 67: France Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 68: France Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 69: France 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 70: France Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 71: France Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 72: France 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 73: Germany Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 74: Germany Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 75: Germany 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 76: Germany Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 77: Germany Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 78: Germany 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 79: Italy Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 80: Italy Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 81: Italy 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 82: Italy Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 83: Italy Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 84: Italy 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 85: UK Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 86: UK Historic Review for Automated Immunoassay
Analyzers by Technology - Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 87: UK 15-Year Perspective for Automated Immunoassay
Analyzers by Technology - Percentage Breakdown of Value Sales
for Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies for the Years 2012, 2020 & 2027

Table 88: UK Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 89: UK Historic Review for Automated Immunoassay
Analyzers by End-Use - Hospitals, Diagnostic Laboratories,
Blood Bank and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 90: UK 15-Year Perspective for Automated Immunoassay
Analyzers by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Laboratories, Blood Bank and Other
End-Uses for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for
Automated Immunoassay Analyzers by Technology -
Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 92: Rest of Europe Historic Review for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 93: Rest of Europe 15-Year Perspective for Automated
Immunoassay Analyzers by Technology - Percentage Breakdown of
Value Sales for Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies for the Years
2012, 2020 & 2027

Table 94: Rest of Europe Current & Future Analysis for
Automated Immunoassay Analyzers by End-Use - Hospitals,
Diagnostic Laboratories, Blood Bank and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 95: Rest of Europe Historic Review for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 96: Rest of Europe 15-Year Perspective for Automated
Immunoassay Analyzers by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank
and Other End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 98: Asia-Pacific Historic Review for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 99: Asia-Pacific 15-Year Perspective for Automated
Immunoassay Analyzers by Technology - Percentage Breakdown of
Value Sales for Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies for the Years
2012, 2020 & 2027

Table 100: Asia-Pacific Current & Future Analysis for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 101: Asia-Pacific Historic Review for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 102: Asia-Pacific 15-Year Perspective for Automated
Immunoassay Analyzers by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank
and Other End-Uses for the Years 2012, 2020 & 2027

REST OF WORLD
Table 103: Rest of World Current & Future Analysis for
Automated Immunoassay Analyzers by Technology -
Immunofluorescence, Chemiluminescence Immunoassay (CLIA),
Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked
Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other
Technologies - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 104: Rest of World Historic Review for Automated
Immunoassay Analyzers by Technology - Immunofluorescence,
Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent
Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 105: Rest of World 15-Year Perspective for Automated
Immunoassay Analyzers by Technology - Percentage Breakdown of
Value Sales for Immunofluorescence, Chemiluminescence
Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay
(ELFA), Enzyme Linked Immunosorbent Assay (ELISA),
Radioimmunoassay (RIA) and Other Technologies for the Years
2012, 2020 & 2027

Table 106: Rest of World Current & Future Analysis for
Automated Immunoassay Analyzers by End-Use - Hospitals,
Diagnostic Laboratories, Blood Bank and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 107: Rest of World Historic Review for Automated
Immunoassay Analyzers by End-Use - Hospitals, Diagnostic
Laboratories, Blood Bank and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 108: Rest of World 15-Year Perspective for Automated
Immunoassay Analyzers by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank
and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 41